Hubei Biocause Pharmaceutical Co., Ltd. (000627)

Overview

Hubei Biocause Pharmaceutical Co., Ltd. is a multifaceted enterprise based in Jingmen, China, with a primary focus on providing life and motor insurance products to the Chinese market. Beyond insurance, the company has diversified interests in the pharmaceutical, chemical, and new energy fuel sectors. The firm is engaged in both research and production activities across a variety of products and services. With an international footprint, Hubei Biocause Pharmaceutical exports its products to approximately 85 countries worldwide, including the United States and the European Union, showcasing its global reach and the diverse markets it serves.

Products and Services

• Life and Motor Insurance: Offering comprehensive insurance solutions tailored to meet the needs of individuals and families in China, the company provides essential financial protection against life's uncertainties.
• Pharmaceuticals: The company is actively involved in contract research and the production of APIs (Active Pharmaceutical Ingredients), intermediates, and various formulations such as tablets, granules, and capsules. These pharmaceutical products are designed to meet rigorous health and safety standards, addressing different therapeutic needs.
• Chemicals: Hubei Biocause Pharmaceutical provides a range of chemicals for industrial applications. This includes the manufacture of dimethyl ether gas, used as an aerosol propellant or a liquefied gas fuel, and a-chloropropionyl chloride, a key intermediate in organic synthesis.
• New Energy Fuels: In line with global sustainability efforts, the company invests in the new energy fuel sector, focusing on the development and production of cleaner, more efficient fuel alternatives to traditional fossil fuels.